Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 20.5.2022Bayer, spol. s r.o. (BAY-SK-2)33060Aspirin 500 mg (tbl 10x500 mg (blis.PP/Al))20.5.2022O
 20.5.2022CANDE s.r.o. (CRR-SK)0382CITOCAN (tbl flm 100x50 mg (blis.PVC/PVDC/Al))20.5.2022O
 20.5.2022CANDE s.r.o. (CRR-SK)0381CITOCAN (tbl flm 40x50 mg (blis.PVC/PVDC/Al))20.5.2022O
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)0566DWobenzym (tbl ent 300 (liek.plast.-klin.bal.))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)3762BPhlogenzym (tbl flm 40 (blis.Al/PVC/PE))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)3763BPhlogenzym (tbl flm 100 (blis.Al/PVC/PE))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)3764BPhlogenzym (tbl flm 200 (blis.Al/PVC/PE))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)3949CWobenzym (tbl ent 40 (blis.PVC/PE/PVDC/Al))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)3950CWobenzym (tbl ent 200 (blis.PVC/PE/PVDC/Al))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)67167Phlogenzym (tbl flm 800 (liek.plast.))29.4.2022R
 19.5.2022MUCOS Pharma GmbH & Co. KG (MUC-3)96406Wobenzym (tbl ent 800 (liek.plast.-klin.bal.))29.4.2022R
 19.5.2022Takeda Manufacturing Austria AG (TKM-5)96279KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x10 ml/1 g (liek.inj.skl.))18.5.2022R
 19.5.2022Ewopharma International, s.r.o. (EWO-SK-2)81327Isoprinosine 500 mg tablety (tbl 100x500 mg (blis. PVC/PVDC/Al))19.5.2022O
 19.5.2022GlaxoSmithKline Trading Services Limited (GAG-IRL-3)39169Augmentin ES (plu por 1x100 ml (fľ.skl.))1.10.2021Z
 19.5.2022CSL Behring GmbH (CSL)50935Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml (liek.inj.skl.))18.5.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)